✦ LIBER ✦

INTRAVESICAL INSTILLATION OF EPIRUBICIN, BACILLUS CALMETTE-GUERIN AND BACILLUS CALMETTE-GUERIN PLUS ISONIAZID FOR INTERMEDIATE AND HIGH RISK TA, T1 PAPILLARY CARCINOMA OF THE BLADDER: A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GENITO-URINARY GROUP RANDOMIZED PHASE III TRIAL

✍ Scribed by VAN DER MEIJDEN, ADRIAN P.M.; BRAUSI, MAURIZIO; ZAMBON, VICTOR; KIRKELS, WIM; DE BALINCOURT, CHRISTINE; SYLVESTER, RICHARD

Book ID: 121253281
Publisher: Lippincott Williams and Wilkins
Year: 2001
Tongue: English
Weight: 140 KB
Volume: 166
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)65966-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Efficacy Results of EORTC Geni

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Richard J. Sylvester; Maurizio A. Brausi; Wim J. Kirkels; Wolfgang Hoeltl; Ferna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Re: Long-Term Efficacy Results of EORTC

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Donald L. Lamm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Re: Long-Term Efficacy Results of EORTC

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin Plus Isoniazid in Patients With Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Wood, David P. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

BACILLUS CALMETTE-GUERIN VERSUS EPIRUBIC

BACILLUS CALMETTE-GUERIN VERSUS EPIRUBICIN FOR PRIMARY, SECONDARY OR CONCURRENT CARCINOMA IN SITU OF THE BLADDER: RESULTS OF A EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER—GENITO-URINARY GROUP PHASE III TRIAL (30906)

✍ DEREIJKE, T; KURTH, K; SYLVESTER, R; HALL, R; BRAUSI, M; VANDEBEEK, K; LANDSOGHT 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 86 KB

RE: BACILLUS CALMETTE-GUERIN VERSUS EPIR

RE: BACILLUS CALMETTE-GUERIN VERSUS EPIRUBICIN FOR PRIMARY, SECONDARY OR CONCURRENT CARCINOMA IN SITU OF THE BLADDER: RESULTS OF A EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER–GENITO-URINARY GROUP PHASE III TRIAL (30906)

✍ Mehraban, Darab; Esfahani, Fatemeh 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 135 KB

Maintenance Bacillus Calmette-Guerin for

Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

✍ Adrian P.M. van der Meijden; Richard J. Sylvester; Wim Oosterlinck; Wolfgang Hoe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 105 KB